glp-1 prescriptions growth slowing 2024 Antagonists Increase Plan Drug Spend - What's Next GLP-1 Prescriptions Quadruple Since 2021

VK2735: oral and injectable in one programme Viking Therapeutics has positioned VK2735, a dual GLP-1 and GIP agonist, as a flexible platform offering both an injection and a pill

People with type 2 diabetes requiring multiple antihypertensive medications For patients struggling to achieve blood pressure targets despite multiple antihypertensive drugs, the additional blood pressure-lowering effect of GLP-1 therapy may contribute to better overall control

Spending and eating less and differently Among US consumers surveyed by PwC, GLP-1 users spent an average of about 11% less on most categories of food, with the largest reductions in sweet and salty snacks and baked foods

(Source 2) Strawberries are the most popular berry, beginning as a wild food in many parts of the world